Preliminary safety report of an ongoing dose-escalation trial of abciximab in acute ischemic stroke

被引：0
|
作者：
Adams, H [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
STROKE | 1999年 / 30卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
74
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [31] Open trial to evaluate efficacy, safety and the dose-escalation of idebenone in patients with Friedreich's ataxia
    Arpa, J.
    Dominguez, F.
    Moreno, M.
    Rodriguez-de-Rivera, F.
    Sarria, M.
    Santiago, S.
    Perez-Conde, C.
    Lopez-Pajares, R.
    Blanco, M.
    JOURNAL OF NEUROLOGY, 2006, 253 : 49 - 49
  • [32] Safety, tolerability, and pharmacokinetics of idebenone in a dose-escalation trial in patients with Friedreich's ataxia.
    Di Prospero, NA
    Sumner, C
    Atkinson, A
    Fischbeck, K
    Taylor, JP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P68 - P68
  • [33] Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial
    Georgoff, Patrick E.
    Nikolian, Vahagn C.
    Bonham, Tess
    Pai, Manjunath P.
    Tafatia, Celia
    Halaweish, Ihab
    To, Kathleen
    Watcharotone, Kuanwong
    Parameswaran, Aishwarya
    Luo, Ruijuan
    Sun, Duxin
    Alam, Hasan B.
    CLINICAL PHARMACOKINETICS, 2018, 57 (02) : 209 - 219
  • [34] Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial
    Patrick E. Georgoff
    Vahagn C. Nikolian
    Tess Bonham
    Manjunath P. Pai
    Celia Tafatia
    Ihab Halaweish
    Kathleen To
    Kuanwong Watcharotone
    Aishwarya Parameswaran
    Ruijuan Luo
    Duxin Sun
    Hasan B. Alam
    Clinical Pharmacokinetics, 2018, 57 : 209 - 219
  • [35] High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)
    Elkind, Mitchell S. V.
    Sacco, Ralph L.
    MacArthur, Robert B.
    Peerschke, Ellinor
    Neils, Greg
    Andrews, Howard
    Stillman, Joshua
    Corporan, Tania
    Leifer, Dana
    Liu, Rui
    Cheung, Ken
    CEREBROVASCULAR DISEASES, 2009, 28 (03) : 266 - 275
  • [36] Safety Analysis of a New Generation Freeze-Dried Plasma Product: Report of a Dose-Escalation, Phase 1 Clinical Trial
    Cancelas, Jose
    Rugg, Neeta
    Nestheide, Shawnagay
    King, Melissa
    Snyder, Michele
    Pehta, Joan C.
    Macdonald, Victor
    Valiyaveettil, Manoj
    Atkinson, Andrew
    TRANSFUSION, 2018, 58 : 10A - 10A
  • [37] Tolerability and safety of perampanel: two randomized dose-escalation studies
    Krauss, G. L.
    Bar, M.
    Biton, V.
    Klapper, J. A.
    Rektor, I.
    Vaiciene-Magistris, N.
    Squillacote, D.
    Kumar, D.
    ACTA NEUROLOGICA SCANDINAVICA, 2012, 125 (01): : 8 - 15
  • [38] Emergency administration of abciximab for treatment of patients with acute ischemic stroke:: Results of an international phase III trial -: Abciximab in emergency treatment of stroke trial (AbESTT-II)
    Adams, Harold P., Jr.
    Effron, Mark B.
    Torner, James
    Davalos, Antoni
    Frayne, Judith
    Teal, Philip
    Leclerc, Jacques
    Oemar, Barry
    Padgett, Lakshmi
    Barnathan, Elliot S.
    Hacke, Werner
    STROKE, 2008, 39 (01) : 87 - 99
  • [39] Dose-escalation study to assess the safety, pharmacokinetics and dose-proportionality of RAD
    Kovarik, JM
    Rordorf, C
    Hartmann, S
    Lecaillon, JB
    Greig, G
    Halabi, A
    TRANSPLANTATION, 1999, 67 (07) : S158 - S158
  • [40] An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease
    Salama, Joseph K.
    Chmura, Steven J.
    Mehta, Neil
    Yenice, Kamil M.
    Stadler, Walter M.
    Vokes, Everett E.
    Haraf, Daniel J.
    Hellman, Samuel
    Weichselbaum, Ralph R.
    CLINICAL CANCER RESEARCH, 2008, 14 (16) : 5255 - 5259
12345